Filter News
Area of Research
News Topics
- (-) Coronavirus (23)
- 3-D Printing/Advanced Manufacturing (28)
- Advanced Reactors (5)
- Artificial Intelligence (41)
- Big Data (25)
- Bioenergy (53)
- Biology (75)
- Biomedical (32)
- Biotechnology (14)
- Buildings (8)
- Chemical Sciences (35)
- Clean Water (14)
- Climate Change (53)
- Composites (11)
- Computer Science (107)
- Critical Materials (15)
- Cybersecurity (9)
- Decarbonization (27)
- Energy Storage (38)
- Environment (111)
- Exascale Computing (24)
- Frontier (28)
- Fusion (9)
- Grid (11)
- High-Performance Computing (53)
- Hydropower (8)
- Irradiation (1)
- Isotopes (13)
- ITER (1)
- Machine Learning (18)
- Materials (83)
- Materials Science (87)
- Mathematics (3)
- Mercury (7)
- Microscopy (35)
- Molten Salt (3)
- Nanotechnology (44)
- National Security (9)
- Net Zero (4)
- Neutron Science (45)
- Nuclear Energy (20)
- Partnerships (12)
- Physics (35)
- Polymers (19)
- Quantum Computing (20)
- Quantum Science (32)
- Renewable Energy (2)
- Security (6)
- Simulation (23)
- Software (1)
- Space Exploration (5)
- Summit (46)
- Sustainable Energy (44)
- Transformational Challenge Reactor (3)
- Transportation (20)
Media Contacts
To better understand the spread of SARS-CoV-2, the virus that causes COVID-19, Oak Ridge National Laboratory researchers have harnessed the power of supercomputers to accurately model the spike protein that binds the novel coronavirus to a human cell receptor.
The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
COVID-19 has upended nearly every aspect of our daily lives and forced us all to rethink how we can continue our work in a more physically isolated world.
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.
Scientists have tapped the immense power of the Summit supercomputer at Oak Ridge National Laboratory to comb through millions of medical journal articles to identify potential vaccines, drugs and effective measures that could suppress or stop the